Additive Beneficial Effects of Beta-Blockers to Angiotensin-Converting Enzyme Inhibitors in the Survival and Ventricular Enlargement (SAVE) Study fn1fn1This study was supported by a University-Industry grant from the Medical Research Council, Ottawa, Ontario, Canada and Bristol Myers Squibb, Montreal, Quebec, Canada.

This publication has 23 references indexed in Scilit:

• Treatment with beta-adrenergic blocking agents after myocardial infarction: From randomized trials to clinical practice
  Journal of the American College of Cardiology, 1995
• Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction.
  Circulation, 1994
• Activation of neurohumoral systems in postinfarction left ventricular dysfunction
  Journal of the American College of Cardiology, 1993
• Effects of beta blockers on ventricular dysfunction after myocardial infarction: Tolerability and survival effects
  The American Journal of Cardiology, 1993
• Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction
  New England Journal of Medicine, 1992
• Relation between beta-adrenergic blocker use, various correlates of left ventricular function and the chance of developing congestive heart failure
  Journal of the American College of Cardiology, 1990
• The Beta-Blocker Pooling Project (BBPP): subgroup findings from randomized trials in post infarction patients
  European Heart Journal, 1988
• Effect of propranolol after acute myocardial infarction in patients with congestive heart failure.
  Circulation, 1986
• Beta blockade during and after myocardial infarction: An overview of the randomized trials
  Progress in Cardiovascular Diseases, 1985
• Influence of heart size on mortality and reinfarction in patients treated with timolol after myocardial infarction.
  Heart, 1983